View Older Stories View More Recent Stories

May 8, 2013 01:21PM ICU Medical (ICUI) Enterprise Value of $1 Billion Implies $82/Share Price

May 8, 2013 07:25AM Roth Capital Upgrades U.S. Auto Parts Network (PRTS) to Buy

May 7, 2013 01:05PM UPDATE: BMO Capital Downgrades Synta Pharma. (SNTA) to Market Perform

May 7, 2013 11:41AM Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp

May 3, 2013 02:49PM Notable 52-Week Highs and Lows of the Day 05/03: (AIG) (STX) (GILD) High; (DCTH) (ZAGG) (VCRA) Low

May 3, 2013 10:41AM Notable Analyst Rating Changes 05/03: (GM) (BZH) (RDC) Upgraded; (DCTH) (SYY) (LULU) Downgraded

May 3, 2013 07:20AM Roth Capital Downgrades Delcath Systems (DCTH) to Sell

May 3, 2013 06:52AM Roth Capital Downgrades ZAGG Incorporated (ZAGG) to Neutral

Apr 8, 2013 08:02AM Roth Capital Starts Hudson Technologies (HDSN) at Buy

Mar 27, 2013 10:57AM NV5 Holdings (NVEEU) IPO Trades Flat

Mar 27, 2013 07:33AM Roth Capital Downgrades Obagi Medical Products (OMPI) to Neutral

Mar 25, 2013 04:04PM Coastal Contacts (COA) Announces Common Stock Offering

Mar 21, 2013 08:33AM Cimatron Limited (CIMT) Offering of 2.5M Shares Priced at $5.25 for Holders

Mar 19, 2013 09:09AM Intellipharmaceutics (IPCI) Commences $.1M Capital Raise Via Direct Offering

Mar 15, 2013 10:46AM Notable Analyst Rating Changes 03/15: (FCX) (CPST) (SEE) Upgraded; (DAL) (SCHW) (PGR) Downgraded

Mar 15, 2013 08:20AM Roth Capital Starts Response Genetics (RGDX) at Buy

Mar 15, 2013 07:04AM Roth Capital Upgrades Capstone Turbine (CPST) to Buy

Mar 14, 2013 07:34AM Roth Capital Starts QuickLogic (QUIK) at Buy

Mar 14, 2013 07:33AM Roth Capital Starts Redhill Biopharma (RDHL) at Buy

Mar 13, 2013 08:16AM Roth Capital Starts TG Therapeutics (TGTX) at Buy

Mar 13, 2013 07:20AM Roth Capital Downgrades GSI Group (GSIG) to Neutral

Mar 13, 2013 07:19AM Roth Capital Starts Verastem (VSTM) at Buy

Mar 7, 2013 11:23AM Roth Capital Downgrades World Wrestling Entertainment (WWE) to Neutral

Mar 7, 2013 07:37AM Roth Capital Downgrades Vitacost.com (VITC) to Sell

Mar 6, 2013 07:29AM Roth Capital Starts Cytori Therapeutics, Inc. (CYTX) at Buy

Mar 5, 2013 09:02AM Wireless Ronin (RNIN) Sinks on $1.56M Offering

Mar 1, 2013 09:36AM Roth Capital Resumes Perry Ellis (PERY) at Buy

Feb 27, 2013 03:07PM Limoneira (LMNR) Underwriters Exercise Full Overallotment in Equity Offering

Feb 21, 2013 02:13PM Roth Capital Upgrades CIBER (CBR) to Buy

Feb 15, 2013 07:32AM Roth Capital Upgrades inContact (SAAS) to Buy

Feb 15, 2013 07:28AM Roth Capital Starts Endocyte (ECYT) at Buy

Feb 14, 2013 08:50AM Plug Power (PLUG) Prices 18.9M Common, Warrants Offering; Sees Gross Proceeds of $2.8M

Feb 13, 2013 08:57AM eGain (EGAN) Prices 2.17M Common Offering at $6.75/Share

Feb 13, 2013 07:32AM Roth Capital Downgrades Meredith Corp (MDP) to Neutral

Feb 11, 2013 08:10AM Roth Capital Starts Hydrogenics (HYGS) at Buy

Feb 8, 2013 11:03AM Notable Analyst Rating Changes 02/08: (ATVI) (UDR) (GES) Upgraded; (NUAN) (SKUL) (CYS) Downgraded

Feb 8, 2013 07:16AM Roth Capital Downgrades Skullcandy (SKUL) to Neutral

Feb 7, 2013 03:11PM Roth Capital Downgrades RTI Biologics (RTIX) to Neutral

Feb 7, 2013 07:39AM Roth Capital Assumes Delta Apparel (DLA) at Buy

Feb 6, 2013 03:41PM Silver Bull (SVBL) Affirms Full Allocation of 22.75M Unit Offering

Feb 5, 2013 08:28AM Roth Capital Starts Comstock Mining (LODE) at Buy

Feb 5, 2013 07:41AM Roth Capital Upgrades A.T. Cross Company (ATX) to Buy

Feb 4, 2013 08:17AM Limoneira (LMNR) Anounces 1.8M Common Offering

Feb 4, 2013 06:53AM Roth Capital Downgrades Graham Corporation (GHM) to Neutral

Jan 31, 2013 02:57PM Roth Capital Downgrades Celsion Corp (CLSN) to Neutral

Jan 31, 2013 10:40AM Notable Analyst Rating Changes 01/31: (FB) (VALE) (AJG) Upgraded; (RF) (PCLN) (VELT) Downgraded

Jan 31, 2013 09:16AM Roth Capital Resumes Joe's Jeans Inc. (JOEZ) at Buy

Jan 31, 2013 06:53AM Keryx Biopharma (KERX) Prices 8.23M Offering at $8.49/Share

Jan 29, 2013 10:50AM Keryx Biopharmaceuticals (KERX) Continues Monumental Run-Up; Analysts See Another 40% Upside

Jan 28, 2013 12:48PM Keryx Biopharmaceuticals (KERX) Gets Another 'Going to $15' Call

View More Recent Stories View Older Stories